NCT04864600

Brief Summary

INTRODUCTION: Particle contamination is suggested to have substantial negative effects on health, with candles emitting huge amount of particles, thus being one of the largest contributors to indoor air pollution. Chronic low levels of exposure to indoor particles over time is an important risk factor for the health of the population as a whole and it becomes particularly important for vulnerable groups like people suffering from respiratory diseases such as asthma. AIM: In a randomized controlled cross-over trial the difference in health effects between two candles I) a standard candle and II) a low emission candle modified from the standard candle is studied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
Last Updated

April 29, 2021

Status Verified

April 1, 2021

Enrollment Period

4 months

First QC Date

November 4, 2020

Last Update Submit

April 28, 2021

Conditions

Keywords

Stearin candleHealth effectsInflammationAsthmaticsParticle contaminationIndoor airPollutant

Outcome Measures

Primary Outcomes (1)

  • Change in Particles in Exhaled Air (Surfactant Protein A & Albumin)

    PExA: Subjects performed repeated breath maneuvers allowing for airway closure and re-opening, and exhaled particles were optically counted and collected on a membrane using the PExA® instrument set-up

    At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)

Secondary Outcomes (12)

  • Change in Lung Function (FEV1 & FVC)

    At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)

  • Change in Fractional exhaled nitric oxide (FENO)

    At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)

  • Change in white blood cells in Blood

    At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)

  • Change in Endothelial Progenitor Cells (EPCs) in Blood

    At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)

  • Change in inflammatory markers in Blood

    At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)

  • +7 more secondary outcomes

Study Arms (3)

Standard Stearin Candle

ACTIVE COMPARATOR

Several candles will be lit. We will be using realistic burning cycles i.e. burning candles which extinguish and new ones being lit.

Other: Candle 1

Modified low emission candle

EXPERIMENTAL

Several candles will be lit. We will be using realistic burning cycles i.e. burning candles which extinguish and new ones being lit.

Other: Candle C

Clean Air

NO INTERVENTION

No candles in the chamber.

Interventions

Burning candles will produce particulate air pollution being passed on an exposure chamber where the participants will be sitting for 5 hours.

Modified low emission candle

Burning candles will produce particulate air pollution being passed on an exposure chamber where the participants will be sitting for 5 hours.

Standard Stearin Candle

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-25
  • Medically treated / physician diagnosed mild seasonal asthma GINA guidelines step 1 or 2 (https://ginasthma.org/)
  • Never smoker or ex-smoker ≥ 6 months
  • Allergy \> 1 common allergy

You may not qualify if:

  • Any other disease that could influence the study parameters
  • Conditions that prevent safe access to the climate chambers (such as claustrophobia)
  • Perennial asthma
  • Need for continuous medical treatment for asthma
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Climate Chambers, Dept. Public Health, Aarhus University

Aarhus, Central Region Denmark, 8000, Denmark

Location

MeSH Terms

Conditions

Signs and SymptomsInflammationAsthma

Condition Hierarchy (Ancestors)

Pathological Conditions, Signs and SymptomsPathologic ProcessesBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Torben Sigsgaard, Prof.

    University of Aarhus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: A randomized cross-over double-blind study under controlled conditions in a climate chamber having three different exposures; A) a standard (Scandinavian) stearin candle, B) a modified low emitting version of the same candle, and C) clean air
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and medical doctor

Study Record Dates

First Submitted

November 4, 2020

First Posted

April 29, 2021

Study Start

September 1, 2020

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

April 29, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations